发明名称 |
Commensal bacteria as singal mediators within a mammalian host |
摘要 |
Genetically engineered cells and microorganisms are provided for preventing or ameliorating diseases through genetically engineered quorum signaling. Therapeutic methods for using the cells and microorganisms to prevent or ameliorate diseases are also provided. The genetically engineered cells or microorganisms can be engineered to express a signal and used to interrupt the signaling-dependent virulence of an invading pathogen. The cells or microorganisms can be used to provide signal-dependent expression of a desirable gene in order to interrupt, prevent, and/or ameliorate a disease of mammals, such as parasitic diseases, infectious diseases, autoimmune diseases and genetic disorders. |
申请公布号 |
US9334503(B2) |
申请公布日期 |
2016.05.10 |
申请号 |
US201414151601 |
申请日期 |
2014.01.09 |
申请人 |
Cornell University |
发明人 |
March John C.;Duan Franklin Faping |
分类号 |
A01N63/00;C12N15/74;C12N15/00;C07H21/04;A23K1/00;C07K14/47;C07K14/605;A61K38/16;A61K38/22;A61K38/26;C12N15/75;A61K35/12 |
主分类号 |
A01N63/00 |
代理机构 |
Pepper Hamilton LLP |
代理人 |
Pepper Hamilton LLP |
主权项 |
1. A method of treating diabetes in a mammalian host comprising:
administering to the gastrointestinal tract of mammalian host a recombinant enteric commensal bacterium comprising a recombinant nucleic acid encoding a signal that comprises a mammalian insulin secretion-stimulating peptide glucagon-like peptide 1 (GLP-1), wherein:
the recombinant nucleic acid encoding the signal is under the control of a promoter,the signal is expressed and secreted by the recombinant enteric commensal bacterium in the gastrointestinal tract of the mammalian host, andthe signal stimulates glucose-responsive insulin production in the mammalian host. |
地址 |
Ithaca NY US |